MIKO logo

Miko NV Stock Price

ENXTBR:MIKO Community·€66.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

MIKO Share Price Performance

€53.60
2.40 (4.69%)
€53.60
2.40 (4.69%)
Price €53.60

MIKO Community Narratives

There are no narratives available yet.

Recent MIKO News & Updates

Miko's (EBR:MIKO) Solid Profits Have Weak Fundamentals

Oct 04
Miko's (EBR:MIKO) Solid Profits Have Weak Fundamentals

Unpleasant Surprises Could Be In Store For Miko NV's (EBR:MIKO) Shares

Apr 03
Unpleasant Surprises Could Be In Store For Miko NV's (EBR:MIKO) Shares

Miko NV Key Details

€303.5m

Revenue

€156.1m

Cost of Revenue

€147.4m

Gross Profit

€144.2m

Other Expenses

€3.2m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
2.56
Gross Margin
48.56%
Net Profit Margin
1.05%
Debt/Equity Ratio
64.2%

Miko NV Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Moderate risk and good value.

5 Risks
3 Rewards

About MIKO

Founded
1801
Employees
1421
CEO
Frans Van Tilborg
WebsiteView website
www.mikogroup.be

Miko NV, together with its subsidiaries, engages in the coffee roasting business under the Miko brand name in Belgium, France, the Netherlands, the United Kingdom, Germany, Denmark, Norway, Sweden, Poland, the Czech Republic, Slovakia, and Australia. It offers various soft drinks, snacks, and healthy snacks, as well as coffee, milk, tea, and hot chocolates. The company also installs coffee and vending machines for companies, public institutions, and universities. Miko NV was founded in 1801 and is based in Turnhout, Belgium.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Belgian Market Performance

  • 7 Days: 4.8%
  • 3 Months: 6.4%
  • 1 Year: 6.8%
  • Year to Date: 13.1%
Over the last 7 days, the market has risen 4.8%, driven by gains of 21% in the Healthcare sector. In the last year, the market has climbed 6.8%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›